Table 1.
Gene | Cre driver | Cell/tissue targeted | Main effects | References |
---|---|---|---|---|
Il1a | Myh6-Cre | Cardiomyocytes | No effect on cardiac tissue remodeling after MI | Bageghni et al. [40] |
Il1b | CMV-Cre | Ubiquitous deletion | Reduces bone metastasis during breast cancer | Tulotta et al. [47] |
CX3CR1-CreER | Microglial cell | Reduces the development of pain | [39] | |
Il1r1 | K14-Cre | Ubiquitous deletion | Mediates peripheral immune response to T. Muris infection | [42] |
Inhibits melanoma inflammatory niche | Young et al. [48] | |||
CMV-Cre | Ubiquitous deletion | Decreases inflammatory responses to systemic challenges | Mufazalov et al. [49]; Mufazalov et al. [50] | |
NI | Robson et al. [41] | |||
PGK-Cre | Ubiquitous deletion | Regulates cardiac tissue remodeling after MI | Bageghni et al. [40] | |
Col1a2-CreER | Fibroblasts | Regulates cardiac tissue remodeling after MI | Bageghni et al. [40] | |
CD4-Cre | T cells | Regulates immune response to CD3 antibody injection | Mufazalov et al. [49] | |
Regulates neuroinflammation in EAE | Mufazalov et al. [50] | |||
Vav-Cre | Myeloid cells | Mediates peripheral immune response to T. Muris infection | Adbulaal et al. [42] | |
Ly6G-Cre | Neutrophils | Reduces the tumorigenic effect of IL-1 | Dmitrieva-Posocco et al. [51] | |
Csf2-Cre | GM-CSF positive cells | Regulates inflammation after EAE | Komuczki et al. [52] | |
CX3CR1-CreER | Microglial cells | Reduces renewal of microglial population | Bruttger et al. [53] | |
Regulates microglial activation after CNS inflammation | Zhu et al. [54]* | |||
No effect on febrile response to IL-1 | Knoll et al. [55]* | |||
Myh11-CreER | Smooth muscle cells | Reduces atheroprotective effect of IL-1 after atherosclerosis | Gomez et al. [56] | |
Pdx1-Cre | Pancreatic cells | Alters glucose homeostasis and triggers β-cell de-differentiation | Burke et al. [57] | |
Slco1c1-CreER | Brain endothelial cells | Reduces CNS inflammation and brain damage after stroke | Wong et al. [58] | |
Reduces fever response to IL-1 | Matsuwaki et al. [59] | |||
Nestin-Cre | Neuronal cells | No effect on febrile response to IL-1 | Matsuwaki et al. [59] | |
Reduces brain damage after stroke | Wong et al. [58] | |||
Trpv1-Cre | Nociceptor sensory neurons | No effect on febrile response to IL-1 | Matsuwaki et al. [59] | |
htPA-Cre | Neural crest cells | No effect on febrile response to IL-1 | Matsuwaki et al. [59] | |
ChAT-Cre | Catecholaminergic neurons | Decreases brain damage after stroke | Wong et al. [58] | |
PF4-Cre | Platelets | No effect on brain damage after stroke | Wong et al. [58] | |
ColVI-CreER | Intestinal mesenchymal cells | No effect on development of intestinal cancer | Koliaraki et al. [60] | |
Hep-Cre | Hepatocytes | Reduces liver injury after acute liver failure | Gehrke et al. [61] | |
CD45-Cre | Leukocytes | No role in IL-1-mediated resistance to Mycobacterium tuberculosis | Bohrer et al. [62] | |
Cdh5-Cre | Vascular endothelial cells | Mediates the anti-tumor properties of T cells. Regulates IL-1-induced brain inflammation | Lee et al. [63] | |
Tie2-Cre | Endothelial cells | Decreases IL-1-induced brain inflammation | Liu et al. [44]# | |
Il1r2 | CMV-Cre | Ubiquitous deletion | Reduces inflammation after arthritis | Martin et al. [45] |
K14-Cre | Ubiquitous deletion | NI | Unpublished** |
For IL-1R1fl/fl mice, all cell-/tissue-specific IL-1R1−/− mice have been generated by IL-1R1fl/fl mouse from Abdulaal et al. [42], except those marked (*), generated by IL-1R1fl/fl mouse from Robson et al. [41]. #In the study of Liu and collaborators (2019), the following mouse lines have also been generated: IL-1R1fl/fl x LysM-Cre, IL-1R1fl/fl x CX3CR1-Cre, IL-1R1fl/fl x Camk2a-Cre, IL-1R1fl/fl x Vglut2-Cre, and IL-1R1fl/fl x GFAP-Cre. **IL-1R2fl/fl mice crossed with K14-Cre mice are reported in the present publication. Cre, constitutive deletion by Cre drivers; Cre-ER, inducible deletion by Cre-ER drivers; EAE, experimental autoimmune encephalomyelitis; MI, myocardial infarction; NI, not indicated